Evidence map›Paper›PMID 21799828›Full record

ArticlePloS one2011

Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity.

Tiffany M Zarrella, Anju Singh, Constantine Bitsaktsis, Tabassum Rahman, Bikash Sahay, Paul J Feustel, Edmund J Gosselin, Timothy J Sellati, Karsten R O Hazlett

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 67 citations in OpenAlex.

  1. Animal modelling with theMicrobiology (Reading, England) · 2025
    Article
  2. Article
  3. TolC and EmrA1 contribute toJournal of bacteriology · 2024
    Article
  4. mBio · 2023
    Article
  5. Article
  6. Review
  7. Soluble antigens derived fromCell reports. Medicine · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. The Francisella tularensis Polysaccharides: What Is the Real Capsule?Microbiology and molecular biology reviews : MMBR · 2020
    Review
  12. Article
  13. Article
  14. Frontiers in microbiology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. DifferentialFrontiers in immunology · 2018
    Article
  19. Article
  20. Further Characterization of the Capsule-Like Complex (CLC) Produced byFrontiers in cellular and infection microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Tiffany M ZarrellaCenter for Immunology and Microbial Disease, Albany Medical College, Albany, New York, United States of America.
Anju Singh
Constantine Bitsaktsis
Tabassum Rahman
Bikash Sahay
Paul J Feustel
Edmund J Gosselin
Timothy J Sellati
Karsten R O Hazlett
Albany Medical Center Hospital · US

Funding

TLR2/NLR Signal Regulation of Protective Immunity to F. TularensisP01AI056320 · NIAID · ALBANY MEDICAL COLLEGE · PI METZGER, DENNIS W · 2003 to 2016
$22.9M
Modulating MMP-9 and Neutrophil Recruitment: A Therapeutic Strategy for TularemiaR01AI075193 · NIAID · ALBANY MEDICAL COLLEGE · PI SELLATI, TIMOTHY J · 2008 to 2011
$1.5M
Mechanisms Involved in, and Development of, FcR-Enhanced Mucosal VaccinationR01AI076408 · NIAID · ALBANY MEDICAL COLLEGE · PI GOSSELIN, EDMUND J · 2009 to 2012
$1.5M
NIAID NIH HHS P01 AI056320NIAID NIH HHS R01 AI075193NIAID NIH HHS R01 AI076408NIAID NIH HHS R01 AI07640801
6 · The paper itself

Abstract

backgroundThe gram-negative bacterium Francisella tularensis survives in arthropods, fresh water amoeba, and mammals with both intracellular and extracellular phases and could reasonably be expected to express distinct phenotypes in these environments. The presence of a capsule on this bacterium has been controversial with some groups finding such a structure while other groups report that no capsule could be identified. Previously we reported in vitro culture conditions for this bacterium which, in contrast to typical methods, yielded a bacterial phenotype that mimics that of the bacterium's mammalian, extracellular phase. METHODS/

findingsSDS-PAGE and carbohydrate analysis of differentially-cultivated F. tularensis LVS revealed that bacteria displaying the host-adapted phenotype produce both longer polymers of LPS O-antigen (OAg) and additional HMW carbohydrates/glycoproteins that are reduced/absent in non-host-adapted bacteria. Analysis of wildtype and OAg-mutant bacteria indicated that the induced changes in surface carbohydrates involved both OAg and non-OAg species. To assess the impact of these HMW carbohydrates on the access of outer membrane constituents to antibody we used differentially-cultivated bacteria in vitro to immunoprecipitate antibodies directed against outer membrane moieties. We observed that the surface-carbohydrates induced during host-adaptation shield many outer membrane antigens from binding by antibody. Similar assays with normal mouse serum indicate that the induced HMW carbohydrates also impede complement deposition. Using an in vitro macrophage infection assay, we find that the bacterial HMW carbohydrate impedes TLR2-dependent, pro-inflammatory cytokine production by macrophages. Lastly we show that upon host-adaptation, the human-virulent strain, F. tularensis SchuS4 also induces capsule production with the effect of reducing macrophage-activation and accelerating tularemia pathogenesis in mice.

conclusionF. tularensis undergoes host-adaptation which includes production of multiple capsular materials. These capsules impede recognition of bacterial outer membrane constituents by antibody, complement, and Toll-Like Receptor 2. These changes in the host-pathogen interface have profound implications for pathogenesis and vaccine development.

Indexed as

Adaptive ImmunityImmunity, InnateAdaptation, PhysiologicalAnimalsAntibodies, BacterialBacterial CapsulesBacterial Outer Membrane ProteinsCell MembraneComplement System ProteinsExtracellular SpaceFrancisella tularensisHumansLipopolysaccharidesMiceMolecular WeightO AntigensAntibodies, BacterialBacterial Outer Membrane ProteinsComplement System ProteinsLipopolysaccharidesO AntigensToll-Like Receptor 2

Identifiers

PMID21799828
PMCPMC3142145
OpenAlexW1968692528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.